Welgene Biotech Co.,Ltd. (6661.TWO)

TWD 20.0

(-9.91%)

Long Term Debt Summary of Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd.'s latest annual long term debt in 2023 was 118.97 Million TWD , up 342.24% from previous year.
Welgene Biotech Co.,Ltd.'s latest quarterly long term debt in 2024 Q2 was 99.75 Million TWD , down -2.63% from previous quarter.
Welgene Biotech Co.,Ltd. reported annual long term debt of 26.9 Million TWD in 2022, down 0.0% from previous year.
Welgene Biotech Co.,Ltd. reported annual long term debt of - TWD in 2021, down -100.0% from previous year.
Welgene Biotech Co.,Ltd. reported quarterly long term debt of 99.75 Million TWD for 2024 Q2, down -2.63% from previous quarter.
Welgene Biotech Co.,Ltd. reported quarterly long term debt of 118.97 Million TWD for 2023 FY, up 342.24% from previous quarter.

Annual Long Term Debt Chart of Welgene Biotech Co.,Ltd. (2023 - 2014)

Historical Annual Long Term Debt of Welgene Biotech Co.,Ltd. (2023 - 2014)

Year	Long Term Debt	Long Term Debt Growth
2023	118.97 Million TWD	342.24%
2022	26.9 Million TWD	0.0%
2021	- TWD	-100.0%
2020	11.28 Million TWD	-49.59%
2019	22.37 Million TWD	0.0%
2018	- TWD	-100.0%
2017	2.01 Million TWD	-52.17%
2016	4.21 Million TWD	-34.28%
2015	6.41 Million TWD	-29.14%
2014	9.05 Million TWD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	112.5 Million TWD	-2.79%
2024 Q2	99.75 Million TWD	-2.63%
2023 FY	118.97 Million TWD	342.24%
2023 Q3	103.51 Million TWD	-4.64%
2023 Q4	118.97 Million TWD	14.93%
2023 Q1	40.57 Million TWD	50.84%
2023 Q2	108.55 Million TWD	167.52%
2022 Q3	3.68 Million TWD	0.0%
2022 Q2	- TWD	0.0%
2022 Q1	- TWD	0.0%
2022 FY	26.9 Million TWD	0.0%
2022 Q4	26.9 Million TWD	630.64%
2021 Q1	8.47 Million TWD	-24.85%
2021 Q3	2.83 Million TWD	-49.91%
2021 Q4	- TWD	-100.0%
2021 FY	- TWD	-100.0%
2021 Q2	5.66 Million TWD	-33.19%
2020 Q4	11.28 Million TWD	-19.83%
2020 FY	11.28 Million TWD	-49.59%
2020 Q3	14.07 Million TWD	-16.5%
2020 Q2	16.85 Million TWD	0.0%
2020 Q1	- TWD	-100.0%
2019 Q2	- TWD	0.0%
2019 Q1	- TWD	0.0%
2019 FY	22.37 Million TWD	0.0%
2019 Q4	22.37 Million TWD	0.0%
2018 Q4	- TWD	0.0%
2018 FY	- TWD	-100.0%
2018 Q1	917 Thousand TWD	-54.54%
2018 Q2	917 Thousand TWD	0.0%
2018 Q3	- TWD	-100.0%
2017 Q2	3.11 Million TWD	0.0%
2017 Q1	3.11 Million TWD	-26.08%
2017 Q4	2.01 Million TWD	0.0%
2017 Q3	2.01 Million TWD	-35.29%
2017 FY	2.01 Million TWD	-52.17%
2016 FY	4.21 Million TWD	-34.28%
2016 Q4	4.21 Million TWD	0.0%
2016 Q3	4.21 Million TWD	0.0%
2015 FY	6.41 Million TWD	-29.14%
2014 FY	9.05 Million TWD	0.0%

Peer Long Term Debt Comparison of Welgene Biotech Co.,Ltd.

Name	Long Term Debt	Long Term Debt Difference
BIONET Corp.	6.03 Million TWD	-1871.024%
DIVA Laboratories, Ltd.	- TWD	-Infinity%
Genetics Generation Advancement Corp.	10.34 Million TWD	-1050.034%
Puriblood Medical Co., Ltd.	43.7 Million TWD	-172.239%
TFBS Bioscience Inc.	101.84 Million TWD	-16.818%